Data update as of 31/12/2025


6.3.2. GRUPO DE PSIQUIATRÍA Y SALUD MENTAL-220606-Baca6.3.2. GRUPO DE PSIQUIATRÍA Y SALUD MENTAL-220606-Baca
2025 DATA

Leader


Research

  • Clinical

Location

Department of Psychiatry
Fundación Jiménez Díaz University Hospital.

Avda. Reyes Católicos, 2. 28040 Madrid (Spain).


Keywords

Mental disorders, depression, schizophrenia, behavioural monitoring, ecological momentary assessment (EMA), and suicide.


Gender perspective

Psiquiatría-01Psiquiatría-01

Summary of activities

In 2025, the Group published numerous scientific articles in peer-reviewed indexed journals, primarily focused on suicide prevention, depression, schizophrenia, artificial intelligence, and the analysis of complex datasets. In addition, the Group secured several competitive grants and research projects. Among these, particular emphasis should be placed on the project "SMARTomicS: Suicide Prevention through Therapeutic Interventions Guided by Digital Phenotyping and Pharmacogenetics", funded under the Research Projects for the Implementation of Personalised Precision Medicine Programme. This project aims to develop innovative strategies for suicide prevention by integrating digital phenotyping tools and pharmacogenetic approaches to support more personalised and effective clinical interventions.


Contributions to society

The Group has contributed to the development of clinical guidelines on suicidal behaviour and has actively participated in research project evaluation committees. In addition, Group members have been involved in public outreach and science communication activities aimed at reducing the stigma associated with mental disorders, particularly that surrounding suicide.

Through these initiatives, the Group seeks to promote awareness, improve mental health literacy, support evidence-based clinical practice, and encourage a more informed and compassionate societal response to mental health conditions and suicidal behaviour

Collaborations

  • Icahn School of Medicine, Mount Sinai Hospital (New York, United States).
  • Department of Signal Theory and Communications, Carlos III University of Madrid (Madrid, Spain).
  • INSERM, University of Montpellier (Montpellier, France).

PhD Theses

Psiquiatría-02Psiquiatría-02


List of publications

Emotion Dysregulation, Impulsivity, and Implicit Cognition in Adolescent with Self-Injurious Thoughts and Behaviors: A Six-Month Prospective Study.

Peñuelas-Calvo I, Taracena-Cuerda M, Moreno M, Cabrera-Redondo S, Álvarez-González V, Puente-García R, Quintana-Saiz B, Jiménez-Bidón A, Porras-Segovia A.

J Clin Med. 2025 Dec 09.14(24).

PMID: 41464609

FI: 2,9

http://dx.doi.org/10.3390/jcm14248705This link opens in a popup window


Impact of difficult-to-treat depression for patients and society: a real-world study.

Benavente S, Parra A, Lopez-Castroman J, Conejero I, Alonso-Torres P, López TC, Carrasco Arteaga P, Baca-García E.

Front Psychiatry. 2025.16:1702137.

PMID: 41446298

FI: 3,2

http://dx.doi.org/10.3389/fpsyt.2025.1702137This link opens in a popup window


Use and outcomes of antipsychotic medications for delusional and paranoid personality disorders: A population-based study.

Gonzalo-deMiguel A, Abascal-Peiró S, Prescription Study Group, Martínez-Alés G, Baca-García E.

Schizophr Res. 2025 Dec 22.288:35-37.

PMID: 41435532

FI: 3,5

http://dx.doi.org/10.1016/j.schres.2025.12.010This link opens in a popup window


Leukocytosis and tobacco use during pregnancy.

López Carpintero N, Giráldez-García C, Carmona Camacho R.

Int J Gynaecol Obstet. 2025 Dec 02.

PMID: 41328701

FI: 2,6

http://dx.doi.org/10.1002/ijgo.70670This link opens in a popup window


Obsessive-compulsive and catatonic symptoms in the early stages of psychosis: Are they related?

Sanchez-Alonso S, Canal-Rivero M, Garrido-Torres N, Baca-Garcia E, Crespo-Facorro B, Barrigon ML, Ruiz-Veguilla M.

Eur Arch Psychiatry Clin Neurosci. 2025 Dec.275(8):2523-2533.

PMID: 41051428

FI: 3,7

http://dx.doi.org/10.1007/s00406-025-02080-2This link opens in a popup window


Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects.

Mora F, Ramos-Quiroga JA, Baca-García E, Crespo JM, Gutiérrez-Rojas L, Madrazo A, Pérez Costillas L, Saiz PA, Tordera V, Vieta E.

Front Psychiatry. 2025.16:1623659.

PMID: 40838256

FI: 3,2

http://dx.doi.org/10.3389/fpsyt.2025.1623659This link opens in a popup window


Depression subtypes, suicidality, and healthcare costs in older adults: results from a naturalistic study.

Conejero I, Porras-Segovia A, Albarracín-García L, Barrigón ML, Lopez-Castroman J, Courtet P, Baca-Garcia E.

Front Psychiatry. 2025.16:1560719.

PMID: 40599227

FI: 3,2

http://dx.doi.org/10.3389/fpsyt.2025.1560719This link opens in a popup window


One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians.

Manchado Perero S, Rodríguez Lorente A, García-Pérez A, Isidro García G, Forcen-Muñoz LA, Ovejero S, Sáez Povedano R, González-Galdámez AL, Iturralde LM, Bonilla MR, Fuentes-Pérez P, Ovejas-Catalán C, Suárez-Pinilla P, Fernandez Abascal Puente B, Omaña Colmenares M, Campos-Navarro MP, Baca-García E, Fernández AL, Benavente-López S, Platero AR, Navalón MB, Sánchez-Alonso S, Vázquez-Bourgon J, Pappa S, García-Carmona JA.

Patient Prefer Adherence. 2025.19:1573-1582.

PMID: 40458740

FI: 2

http://dx.doi.org/10.2147/PPA.S517038This link opens in a popup window


Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y).

Manchado Perero S, Rodríguez Lorente A, García-Pérez A, Isidro García G, Forcen-Muñoz LA, Ovejero García S, Sáez Povedano R, González-Galdámez AL, Mata Iturralde L, Ramirez Bonilla M, Fuentes-Pérez P, Ovejas-Catalán C, Suárez-Pinilla P, Fernández Abascal B, Omaña Colmenares M, Campos-Navarro MP, Baca-García E, Lara Fernández A, Benavente-López S, Raya Platero A, Barberán Navalón M, Sánchez-Alonso S, Vázquez-Bourgon J, Pappa S, García-Carmona JA.

Front Psychiatry. 2025.16:1540213.

PMID: 40104335

FI: 3,2

http://dx.doi.org/10.3389/fpsyt.2025.1540213This link opens in a popup window


Psychiatry at the turn of the century and a vision for future developments.

Oquendo MA, Barrigon ML, Baca-Garcia E.

Int Rev Psychiatry. 2025 Nov 19:1-15.

PMID: 41258672

FI: 3,4

http://dx.doi.org/10.1080/09540261.2025.2591200This link opens in a popup window


Association Between Trauma, Impulsivity, and Functioning in Suicide Attempters.

Escobedo-Aedo PJ, Porras-Segovia A, Barrigón ML, Courtet P, López-Castroman J, Baca-Garcia E.

Behav Sci (Basel). 2025 Sep 15.15(9).

PMID: 41009292

FI: 2,5

http://dx.doi.org/10.3390/bs15091262This link opens in a popup window


The Relation Between Violence and Suicidality in Mexico: The Impact of Different Types of Violence in Suicidal Behaviour Detected by a Massive Mental Health Screening App (MeMind).

Molina-Pizarro CA, Lopez-Fernandez O, Villasante-Soriano P, Martinez-Nicolas I, Aroca-Bisquert F, Méndez-Bustos P, Giner L, Baca-García E.

Behav Sci (Basel). 2025 Aug 18.15(8).

PMID: 40867474

FI: 2,5

http://dx.doi.org/10.3390/bs15081117This link opens in a popup window


Esketamine use in real-world clinical practice in patients with treatment-resistant depression.

Conejero I, Alvarez García R, Porras-Segovia A, De Granda Beltrán AM, Benavente López S, Di Stasio E, Albarracín-García L, Lopez-Castroman J, Courtet P, Baca-Garcia E, Memind Group.

Eur Psychiatry. 2025 Aug 26.68(1):e158.

PMID: 40856202

FI: 6,7

http://dx.doi.org/10.1192/j.eurpsy.2025.10096This link opens in a popup window


Impulsivity and aggression in suicide across age and sex: case-control study.

Sanz-Gómez S, Vera-Varela C, de-la-Vega-Sánchez D, Barrigón ML, Alacreu-Crespo A, Guija JA, Sánchez A, de León S, Baca-García E, Giner L.

BJPsych Open. 2025 Aug 01.11(5):e167.

PMID: 40744472

FI: 3,5

http://dx.doi.org/10.1192/bjo.2025.10076This link opens in a popup window


Executive function and quality of life in children and adolescents with type 1 diabetes: The mediating role of the Child Behavior Checklist Dysregulation Profile.

Martin-Martinez N, Caro-Cañizares I, Carballo JJ, Parellada M.

Eur J Pediatr. 2025 Jun 25.184(7):446.

PMID: 40560466

FI: 2,6

http://dx.doi.org/10.1007/s00431-025-06266-7This link opens in a popup window


Impact of Digital Safety Plan Activation on Subsequent Emergency Departments Visits Following an Initial Suicide Attempt: Quasi-Experimental Study.

Barrigón ML, Schmidt C, Elices M, Porras-Segovia A, De Granda-Beltrán AM, Artés-Rodríguez A, Courtet P, Pérez-Sola V, Baca-García E.

JMIR Ment Health. 2025 Jun 17.12:e70253.

PMID: 40526825

FI: 5,8

http://dx.doi.org/10.2196/70253This link opens in a popup window


Feasibility of digital monitoring in patients receiving ambulatory psychiatric care.

Conejero I, Villalba MÁ, Matos V, Jiménez O, García R, Albarracín-García L, Porras-Segovia A, Barrigón ML, Lopez-Castroman J, Artés-Rodriguez A, Baca-Garcia E.

J Psychiatr Res. 2025 May 28.189:184-192.

PMID: 40516300

FI: 3,2

http://dx.doi.org/10.1016/j.jpsychires.2025.05.072This link opens in a popup window


Multiple emergency department visits and suicidal behavior in children and adolescents.

Merayo-Cano JM, Porras-Segovia A, Taracena-Cuerda M, García SM, Marti-Estevez I, Carrillo-Notario L, Martinez-Martín N, Álvarez-García R, Baca-García E, Peñuelas-Calvo I.

J Psychiatr Res. 2025 May.185:84-92.

PMID: 40168743

FI: 3,2

http://dx.doi.org/10.1016/j.jpsychires.2025.03.029This link opens in a popup window


Characteristics of Self-Harm in an Emergency Situation Among Youth: A Longitudinal Five- Year Cohort Study.

Varo C, Barrigón ML, Rider J, Reguera P, Mayo-Jaraquemada A, Canal-Rivero M, Garrido-Torres N, Baca-Garcia E, Ruiz-Veguilla M, Crespo-Facorro B.

Res Child Adolesc Psychopathol. 2025 Apr 26.

PMID: 40285950

FI: 2,4

http://dx.doi.org/10.1007/s10802-025-01309-xThis link opens in a popup window


The Implementation of Shared Decision-Making Using Patient Decision Aid Tools to Select Breast Cancer Treatment Options: A Systematic Review in the Time of Minimum Quality Standards.

Lopez-Fernandez O, Aguilar Castillo CP, Horrillo B, Sánchez de Molina Ramperez ML, Guadalajara H.

Healthcare (Basel). 2025 Mar 27.13(7).

PMID: 40218046

FI: 2,7

http://dx.doi.org/10.3390/healthcare13070748This link opens in a popup window


Reflections on the Potential and Risks of AI for Scientific Article Writing after the AI Endorsement by Some Scientific Publishers: Focusing on Scopus AI.

De Leon J, De Leon-Martinez S, Artés-Rodríguez A, Baca-García E, De Las Cuevas C.

Actas Esp Psiquiatr. 2025 Mar.53(2):433-442.

PMID: 40071362

FI: 1,6

http://dx.doi.org/10.62641/aep.v53i2.1849This link opens in a popup window


Predictors of Suicide Attempts and Reattempts in a Sample of Chilean Adolescents.

Escobedo-Aedo PJ, Méndez P, Álvarez R, Baca-García E, Porras-Segovia A.

Early Interv Psychiatry. 2025 Mar.19(3):e70024.

PMID: 40050958

FI: 2,2

http://dx.doi.org/10.1111/eip.70024This link opens in a popup window


Artificial intelligence in healthcare: Revolution or unfulfilled promise?

Anmella G, Baca-García E.

Eur Neuropsychopharmacol. 2025 Feb 15.94:1-3.

PMID: 39956012

FI: 6,7

http://dx.doi.org/10.1016/j.euroneuro.2025.01.006This link opens in a popup window


Projects, contracts and observational studies

PUBLICS

Sources of public funding for projects being developed at the IIS-FJD:

_FINANCIACIÓN-261007_FINANCIACIÓN-261007

REFERENCE

PROJECT TITLE

PRINCIPAL RESEARCHER

TYPE OF PROJECT

TOTAL FUNDING

PI23/00614

SURVIVE 2: UN ESTUDIO DE COHORTE EXTENDIDA PARA INVESTIGAR LA CONDUCTA SUICIDA EN ESPAÑA Y LA EFICACIA DE ESTRATEGIAS DE PREVENCIÓN SECUNDARIA. SUB-PROYECTO 2. FENOTIPO DIGITAL DE LA CONDUCTA SUICIDA.

BACA GARCIA, ENRIQUE

CLINICAL RESEARCH PROJECTS. ISCIII

€147,500.00

PMP24/00026

SMARTOMICS: PREVENCIÓN DE LA CONDUCTA SUICIDA MEDIANTE INTERVENCIONES TERAPEÚTICAS GUIADAS POR FENOTIPO DIGITAL Y FARMACOGENÉTICA: ENSAYO CLÍNICO ALEATORIZADO PARA EVALUAR LA EFECTIVIDAD EN LA PREVENCIÓN DE LA CONDUCTA SUICIDA DE INTERVENCIONES TERAPÉUTICAS GUIADAS POR FENOTIPO DIGITAL Y FARMACOGENÉTICA.

BACA GARCIA, ENRIQUE

CLINICAL TRIALS WITH OTHER PRODUCTS OR PROCEDURES. ISCIII

€3,541,874.49

S2022/BMD-7216

AMBIENTE Y GENES EN ESQUIZOFRENIA (AGES-CM 3)

BACA GARCIA, ENRIQUE

CLINICAL RESEARCH PROJECTS. CAM

€36,800.00

TEC-2024/COM-224

PROYECTO ALENTAR-J-CM: APLICACIÓN DE MODELOS DEL LENGUAJE A GRAN ESCALA PARA LA PREVENCIÓN SOCIOSANITARIA DE PROBLEMAS DE SALUD MENTAL Y RIESGO DE SUICIDIO EN JÓVENES

BACA GARCIA, ENRIQUE

CLINICAL RESEARCH PROJECTS. CAM

€72,145.78

JR22/00011

CONTRATO JUAN RODÉS: ALEJANDRO PORRAS SEGOVIA.

PORRAS SEGOVIA, ALEJANDRO

POSTDOCTORAL RESEARCH. ISCIII

€180,000.00


PRIVATE

REFERENCE

PROJECT TITLE

PRINCIPAL RESEARCHER

TYPE OF PROJECT

202226-31

A MULTI-SITE-TWO-YEAR FOLLOW-UP STUDY OF THE SURVIVE COHORT: PREVENTING SUICIDE USING A SMARTPHONE-BASED ECOLOGICAL MOMENTARY INTERVENTION (SURVIVE-SMART)

BACA GARCIA, ENRIQUE

RESEARCH PROJECTS. COMPETITIVE

HR23-00421

MULTISITE SMARTPHONE-BASED ECOLOGICAL MOMENTARY INTERVENTION FOR SUICIDE PREVENTION

BACA GARCIA, ENRIQUE

RESEARCH PROJECTS. COMPETITIVE

7931/001

PLAN DE SEGURIDAD DIGITAL PARA LA PREVENCIÓN DE LAS CONDUCTAS SUICIDA Y AUTOLESIVA EN ADOLESCENTES (SMARTCRISIS-TEEN)

PORRAS SEGOVIA, ALEJANDRO

RESEARCH PROJECTS. COMPETITIVE

ECR-1-101-23

EFFECTIVENESS OF PHARMACOLOGICAL INTERVENTIONS TO PREVENT SUICIDAL BEHAVIORS AMONG INDIVIDUALS AT HIGH SUICIDE RISK: A TARGET TRIAL EMULATION

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES. COMPETITIVE

2024.089

PREVENCIÓN E INTERVENCIÓN PRECOZ EN PACIENTES CON RIESGO SUICIDA

BACA GARCIA, ENRIQUE

RESEARCH PROJECTS

2024.093

PREVENCIÓN E INTERVENCIÓN PRECOZ EN PACIENTES CON RIESGO SUICIDA

BACA GARCIA, ENRIQUE

RESEARCH PROJECTS

EO071-21_FJD

ITINERARIOS DE CUIDADO DEL TRASTORNO DEPRESIVO A TRAVÉS DE LA BDD MEMIND. EL PAPEL DE URGENCIAS

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES

EO266-24_FJD

IMPACT OF PPLATS ON CLINICAL OUTCOMES IN SCHIZOPHRENIA THROUGH MEMIND DB - THE ROLE OF ANTIPSYCHOTICS WITH LONGER INTERVAL OF ADMINISTRATION

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES

EOH009-23_HRJC

ESTUDIO OBSERVACIONAL, NATURALÍSTICO, TRANSVERSAL PARA DESCRIBIR EL USO DE ESKETAMINA EN PULVERIZADOR NASAL EN LA DEPRESIÓN RESISTENTE AL TRATAMIENTO EN PRÁCTICA CLÍNICA REAL.ESTUDIO INTEGRATE

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES

EOH017-24_FJD

ESTUDIO DE LAS CARACTERÍSTICAS DE LA ENFERMEDAD Y LA EFICACIA DEL TRATAMIENTO HABITUAL EN LA VIDA REAL EN PACIENTES CON TRASTORNO DEPRESIVO MAYOR (TDM) CON ANHEDONIA Y RESPUESTA INADECUADA AL TRATAMIENTO ANTIDEPRESIVO ACTUAL, INCLUIDO UN ISRS O UN IRSN – ESTUDIO VENTURA RWE

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES

EOH045-25_FJD

ESTUDIO COHORTES, NO INTERVENCIONISTA, PROSPECTIVO, DE PRACTICA REAL PARA EVALUAR LA REMISIÓN FUNCIONAL EN PACIENTES CON TRD TRATADOS CON ESKETAMINA INTRANASAL

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES

EOH045-25_HGV

ESTUDIO COHORTES, NO INTERVENCIONISTA, PROSPECTIVO, DE PRACTICA REAL PARA EVALUAR LA REMISIÓN FUNCIONAL EN PACIENTES CON TRD TRATADOS CON ESKETAMINA INTRANASAL

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES

EOH045-25_HIE

ESTUDIO COHORTES, NO INTERVENCIONISTA, PROSPECTIVO, DE PRACTICA REAL PARA EVALUAR LA REMISIÓN FUNCIONAL EN PACIENTES CON TRD TRATADOS CON ESKETAMINA INTRANASAL

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES

EOH045-25_HRJC

ESTUDIO COHORTES, NO INTERVENCIONISTA, PROSPECTIVO, DE PRACTICA REAL PARA EVALUAR LA REMISIÓN FUNCIONAL EN PACIENTES CON TRD TRATADOS CON ESKETAMINA INTRANASAL

BACA GARCIA, ENRIQUE

OBSERVATIONAL STUDIES

EOH007-24_HIE

PREVALENCE OF ADHD AND HEALTH OUTCOMES IN ADULT OUTPATIENTS WITH PSYCHIATRIC DISORDERS: A MULTI-COUNTRY, TWO-PART, OBSERVATIONAL STUDY.

BENAVENTE LOPEZ, SERGIO

OBSERVATIONAL STUDIES

EOH039-23_HRJC

RISPERIDONE ISM® EFFECTIVENESS IN SCHIZOPHRENIA PATIENTS HOSPITALISED DUE TO A RELAPSE: A PROSPECTIVE NON-INTERVENTIONAL EVALUATION

RENOVELL BUENO, IRENE

OBSERVATIONAL STUDIES

PIC052-23_FJD

ESTUDIO DE COHORTES NO INTERVENCIONISTA SOBRE EL AEROSOL NASAL DE ESKETAMINA EN LA DEPRESIÓN RESISTENTE AL TRATAMIENTO – "ECHO"

BACA GARCIA, ENRIQUE

RESEARCH PROJECTS



Clinical trials

The clinical trials listed below were in the recruitment phase in 2025. If you are interested in participating in any of the currently open trials, more information is available on the website (https://ensayos.quironsalud.es/)

EudraCT Number

TITLE

PHASE

MC1

INT2

PRINCIPAL RESEARCHER

2020-003744-84

ESTUDIO DE FASE III, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE ICLEPERTIN UNA VEZ AL DÍA DURANTE UN PERIODO DE TRATAMIENTO DE 26 SEMANAS EN PACIENTES CON ESQUIZOFRENIA (CONNEX-2)

III

YES

YES

ENRIQUE BACA GARCIA

2020-003745-11

ESTUDIO DE EXTENSIÓN, ABIERTO, DE UN ÚNICO GRUPO, PARA ESTUDIAR LA SEGURIDAD A LARGO PLAZO DE BI 425809, UNA VEZ AL DÍA, EN PACIENTES CON ESQUIZOFRENIA QUE HAYAN COMPLETADO UN ESTUDIO PREVIO DE FASE III DE BI 425809. (CONNEX-X)

III

YES

YES

ENRIQUE BACA GARCIA

2022-002339-73

ESTUDIO EN FASE III, MULTICÉNTRICO, CONTROLADO, ALEATORIZADO Y CON ENMASCARAMIENTO DOBLE PARA INVESTIGAR LA EFICACIA, LA SEGURIDAD Y LA TOLERABILIDAD DE DOS ADMINISTRACIONES DE COMP360 EN PARTICIPANTES QUE SUFREN DEPRESIÓN RESISTENTE AL TRATAMIENTO

III

YES

YES

ENRIQUE BACA GARCIA

2023-509070-36-00

A TWO-PART MULTICENTER, DOUBLE-BLIND, RANDOMIZED PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY AND THE MAINTENANCE OF EFFECT OF 20-MG SELTOREXANT AS ADJUNCTIVE THERAPY TO ANTIDEPRESSANTS IN ADULT AND ELDERLY PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH INSOMNIA SYMPTOMS

III

YES

YES

ENRIQUE BACA GARCIA

NA

SMARTOMICS: PREVENCIÓN DE LA CONDUCTA SUICIDA MEDIANTE INTERVENCIONES TERAPEÚTICAS GUIADAS POR FENOTIPO DIGITAL Y FARMACOGENÉTICA: ENSAYO CLÍNICO ALEATORIZADO PARA EVALUAR LA EFECTIVIDAD EN LA PREVENCIÓN DE LA CONDUCTA SUICIDA DE INTERVENCIONES TERAPÉUTICAS GUIADAS POR FENOTIPO DIGITAL Y FARMACOGENÉTICA.

IV

YES

NO

BACA GARCIA, ENRIQUE

NA

PLATAFORMA DIGITAL PARA LA EVALUACIÓN Y PREVENCIÓN DE LAS CONDUCTAS SUICIDA Y AUTOLESIVA EN ADOLESCENTES (SMARTCRISIS-TEEN)

NA

YES

NO

ALEJANDRO PORRAS SEGOVIA

NA

EVALUACIÓN DE LAS AUTOLESIONES Y PREVENCIÓN DEL RIESGO EN PERSONAS JÓVENES

NA

YES

NO

ALEJANDRO PORRAS SEGOVIA

NA

EFECTIVIDAD DE UNA INTERVENCIÓN ECOLÓGICA MOMENTÁNEA MEDIANTE SMARTPHONES PARA LA PREVENCIÓN DE LA CONDUCTA SUICIDA: ENSAYO CLÍNICO ALEATORIZADO (SMARTCRISIS 3.0)

NA

YES

NO

ENRIQUE BACA GARCIA

MC1: MULTICENTRE INT2: INTERNATIONAL